(Q28188328)

2

object named as

Stephen D Silberstein

0 references

Timothy R. Smith

5

object named as

Timothy R Smith

0 references

author name string

Jerome Goldstein

1

0 references

Joel R Saper

3

0 references

Arthur H Elkind

4

0 references

R Michael Gallagher

6

0 references

Jean-Pierre Battikha

7

0 references

Howard Hoffman

8

0 references

Jeffrey Baggish

Migraine diagnosis and treatment: results from the American Migraine Study II.

9

0 references

language of work or name

English

0 references

publication date

September 2005

0 references

published in

Headache

0 references

volume

45

0 references

issue

8

0 references

page(s)

973-82

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Early treatment of migraine with rizatriptan: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Early intervention with almotriptan improves sustained pain-free response in acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Effect of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X

Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05177.X